ArticleCancer cell international2012

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo.

Zhi-Jun Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.